Evidence map›Paper›PMID 42636369›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Enterochromaffin cells as a cellular integration hub for cooperative microbial signaling to modulate gut serotonin and motility.

Yang Xiao, Tijs Louwies, Ruben A T Mars, Lisa M Till, Yash Gupta, Arnaldo Mercado-Perez, Aditya V Bhagwate, Shreya S Bellampalli, Alejandro Stark Quiroz, Prabhjot K Sekhon and 23 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Yang XiaoDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905.
Tijs LouwiesDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905.
Ruben A T MarsDivision of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN 55905.
Lisa M TillDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905.
Yash GuptaDepartment of Medicine, Penn State College of Medicine, Hershey, PA 17033.
Arnaldo Mercado-PerezDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905.
Aditya V BhagwateDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905.
Shreya S BellampalliDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905.ORCID 0000-0003-3969-1155
Alejandro Stark QuirozDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905.ORCID 0000-0003-0625-5605
Prabhjot K SekhonDivision of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN 55905.
Vaidhvi SinghDivision of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN 55905.
Rongfang LiuLeiden Academic Centre for Drug Research, Division of Medicinal Chemistry, Leiden 2333 CC, The Netherlands.ORCID 0000-0003-0136-8811
Laura H HeitmanLeiden Academic Centre for Drug Research, Division of Medicinal Chemistry, Leiden 2333 CC, The Netherlands.
Dennis TienterDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905.
Michael A ThompsonDepartment of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN 55905.ORCID 0009-0002-2295-9207
Kimberlee F KossickDivision of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN 55905.ORCID 0000-0001-8120-7617
Eugene W KruegerDepartment of Biochemistry and Molecular Biology and Center for Basic Research in Digestive Diseases, Mayo Clinic, Rochester, MN 55905.
Krishna R KalariDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905.
Kaitlyn R HawkinsDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905.
Jeong-Heon LeeEpigenomics Development Laboratory, Mayo Clinic, Rochester, MN 55905.ORCID 0000-0003-4007-9166
Brian S EdwardsDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905.
Daan van der EsLeiden Academic Centre for Drug Research, Division of Medicinal Chemistry, Leiden 2333 CC, The Netherlands.ORCID 0000-0003-3662-8177
Constanza AlcainoInstitute of Metabolic Science Metabolic Research Laboratories, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom.
Julia L E WillettDepartment of Microbiology and Immunology, University of Minnesota Medical School, Minneapolis, MN 55455.ORCID 0000-0002-0524-8289
Preedajit WongkrasantDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905.ORCID 0000-0002-9855-1454
Chun-Jun GuoJill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, Cornell University, New York, NY 10021.
Y S PrakashDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905.ORCID 0000-0002-2968-224X
Brooke R DrulinerDivision of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN 55905.
Tamas OrdogDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905.ORCID 0000-0002-3940-7284
Gianrico FarrugiaDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905.ORCID 0000-0003-3473-5235
Arthur BeyderDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905.ORCID 0000-0002-9225-4854
Kristen M Smith-EdwardsDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905.
Purna C KashyapDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905.ORCID 0000-0002-2851-2388

Funding

PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI Samar Ibrahim · 2009 to 2026
$22.2M
Mechanisms of alteration of GI physiology by gut microbesR01DK114007 · NIDDK · MAYO CLINIC ROCHESTER · PI Purna C Kashyap · 2017 to 2026
$4.7M
MECHANISMS OF VISCERAL PAIN DRIVEN BY SMALL INTESTINAL MICROBIOTAR01DK138818 · NIDDK · MAYO CLINIC ROCHESTER · PI Arthur Beyder, Purna C Kashyap · 2023 to 2026
$3.9M
Epigenetic dysregulation in diabetic enteric neuropathyR01DK126827 · NIDDK · MAYO CLINIC ROCHESTER · PI ORDOG, TAMAS · 2021 to 2024
$2.1M
Molecular mechanisms behind microbiota regulation of host amino acid and glucose homeostasisR01DK135816 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI Chun-Jun Guo · 2023 to 2026
$1.9M
Molecular mechanisms of sexually dimorphic traits of interstitial cells of Cajal and their role in gastrointestinal neuromuscular disordersR01DK142826 · NIDDK · MAYO CLINIC ROCHESTER · PI Tamas Ordog · 2026 to 2026
$635k
Functional genomics of hypothetical genes in Gram-positive bacteriaR00AI151080 · NIAID · UNIVERSITY OF MINNESOTA · PI WILLETT, JULIA · 2023 to 2024
$498k
HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R00AI151080HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) P30DK084567HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01DK114007HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01DK126827HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01DK135816HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01DK138818NIAID NIH HHS R00 AI151080NIDDK NIH HHS P30 DK084567NIDDK NIH HHS R01 DK114007NIDDK NIH HHS R01 DK126827NIDDK NIH HHS R01 DK135816NIDDK NIH HHS R01 DK138818NIDDK NIH HHS R01 DK142826
6 · The paper itself

Abstract

The intestinal epithelium is exposed to diverse combinations of microbiota-derived compounds; however, the mechanisms by which the host integrates these signals remain poorly defined. Studying two highly abundant microbial metabolites, we identified the purine metabolite hypoxanthine as an effector metabolite that directly drives signaling and the short-chain fatty acid butyrate as a regulatory metabolite that conditions host responsiveness. Specifically, hypoxanthine activates the adenosine A1 receptor-TRPC4 axis in enterochromaffin (EC) cells, triggering calcium influx and serotonin release resulting in accelerated gastrointestinal transit locally and increased platelet activation systemically. In contrast, butyrate epigenetically upregulates specific G protein-coupled receptors and ion channels to enhance response to hypoxanthine and the neurotransmitters norepinephrine and dopamine. These findings define a cooperative signaling framework and highlight the role of EC cells as a distinct epithelial signaling hub that senses and integrates microbial metabolite signals to drive physiological responses. Our findings provide a mechanistic foundation for therapeutic strategies that leverage combinatorial microbial signaling.

Indexed as

Enterochromaffin CellsGastrointestinal MotilitySerotoninAnimalsHumansIntestinal MucosaMiceSignal TransductionSerotoninairwayIBSmetabolitesmotility

Identifiers

PMID42636369
PMCPMC13535179

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.